Biosimilars Download Insurance Coverage and Processing 
Pharmacy Times
JULY 16, 2025
Importantly, ACIP’s recommendations do have a strong influence, if not a mandate, on health insurance companies with respect to coverage and co-payments for immunizations as well as the Vaccines for Children Program, which provides coverage for access to vaccines for those who are 18 years or younger.
Pharmaceutical Technology
JULY 23, 2025
Reports Prescriber Opinions on Biosimilars in Immunology Data Insights The gold standard of business intelligence. Decentralising manufacturing has previously been seen as an “up-and-coming development” in the cell and gene therapy sector due to high costs associated with setting up these processes. You will receive an email shortly.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Commerce
JUNE 17, 2025
Artificial intelligence addresses key limitations of traditional health technology assessments—such as data gaps and time-intensive processes—through automation, real-time data integration, and advanced predictive modeling, leading to faster and more informed decisions. In order to automate and enhance these tasks, AI-driven NLP can assist.
Pharmacy Times
AUGUST 11, 2025
Most MTM platforms use health plan adjudication data, allowing pharmacists to see any medication billed through the patient’s insurance, even if it was not filled at their pharmacy. Quality of care transition, patient safety incidents, and patients’ health status: a structural equation model on the complexity of the discharge process.
Pharmacy Times
JULY 22, 2025
These third-party administrators act as intermediaries between drug manufacturers, pharmacies, and insurance companies. PBMs negotiate prices, establish formularies, and process claims, while also creating preferred networks of pharmacies. Additionally, the role of pharmacy benefit managers (PBMs) cannot be overlooked.
Pharmacy Times
JUNE 16, 2025
The first one was introduced on September 13, 2020, near the end of Trump’s first term, but was shut down by a federal judge due to the administration’s failure to comply with the proper implementation processes. Second, it does not address the core issues of higher prices, such as the use of rebates by insurers.
Pharmaceutical Commerce
JUNE 17, 2025
They also experience some of the same problems that manufacturers and distributors face, like spotty tracking information due to the manual processes associated with barcode scanning of drugs. Large hospital systems, for example, have medications distributed among many different pharmacies and departments. References 1. FDA at a Glance.
Expert insights. Personalized for you.
Let's personalize your content